Main public logs

Combined display of all available logs of CAMIH. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

11:05, 1 July 2024 MKraft talk contribs created page Côté et al. (2016): Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial (Created page with "{{Reference |Reference=Publication: Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial }} =Brief summary= In the study, 56 patients with head and neck tumors were randomly divided into 2 groups, one of which received nabilone (synthetic THC) every day and the other a placebo. All patients received radiotherapy or a combination of radiotherapy and chemotherapy for 7 weeks. At...")
11:03, 1 July 2024 MKraft talk contribs created page Publication: Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial (Created page with "{{Publication |Title=Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial |Topic=Cannabinoids |Author=Côté, M; Trudel, M; Wang, C; Fortin, A |Year=2016 |Journal=Annals of Otology, Rhinology & Laryngology |DOI=https://doi.org/10.1177/0003489415612801 |Authors Abstract=Objectives: Patients treated for head and neck carcinomas experience a significant deterioration of their qua...")
07:35, 1 July 2024 DDeel talk contribs moved page Lin et al. (2008): Publication: Effects of zinc supplementation on clinical outcomes in patients receiving radiotherapy for head and neck cancers: a double-blinded randomized study to Lin et al. (2008): Effects of zinc supplementation on clinical outcomes in patients receiving radiotherapy for head and neck cancers: a double-blinded randomized study without leaving a redirect
11:40, 30 June 2024 EProba talk contribs created page Nguyen et al. (2012): Randomized, Double-Blind, Placebo-Controlled Trial of Polyphenon E in Prostate Cancer Patients before Prostatectomy: Evaluation of Potential Chemopreventive Activities (Created page with "{{Reference |Reference=Publication: Randomized, Double-Blind, Placebo-Controlled Trial of Polyphenon E in Prostate Cancer Patients before Prostatectomy: Evaluation of Potential Chemopreventive Activities }} =Brief summary= In this study, 50 patients with prostate cancer were randomly assigned to one of two groups. One group took four polyphenon E capsules (totalling 800mg EGCG) every morning, while the other group received a matching placebo. Neither the participants nor...")
11:24, 30 June 2024 EProba talk contribs created page Nguyen, M.; Ahmann, F.; Nagle, R.; Hsu, C.-H.; Tangrea, J.; Parnes, H.; Sokoloff, M.; Gretzer, M.; Chow, H.-H. S. (Created page with "{{Author}}")
11:23, 30 June 2024 EProba talk contribs created page Publication: Randomized, Double-Blind, Placebo-Controlled Trial of Polyphenon E in Prostate Cancer Patients before Prostatectomy: Evaluation of Potential Chemopreventive Activities (Created page with "{{Publication |Title=Randomized, Double-Blind, Placebo-Controlled Trial of Polyphenon E in Prostate Cancer Patients before Prostatectomy: Evaluation of Potential Chemopreventive Activities |Topic=Green tea (EGCG) |Author=Nguyen, M.; Ahmann, F.; Nagle, R.; Hsu, C.-H.; Tangrea, J.; Parnes, H.; Sokoloff, M.; Gretzer, M.; Chow, H.-H. S. |Year=2012 |Journal=Cancer Prevention Research |DOI=https://doi.org/10.1158/1940-6207.CAPR-11-0306 |Authors Abstract=Compelling preclinical...")
08:56, 30 June 2024 DDeel talk contribs created page Toma et al. (2003): β-carotene supplementation in patients radically treated for stage I-II head and neck cancer: Results of a randomized trial (Created page with "{{Reference |Reference=Publication: β-carotene supplementation in patients radically treated for stage I-II head and neck cancer: Results of a randomized trial }} =Brief summary= This study examined patients with head and neck cancer, half of whom took beta-carotene (i.e. a precursor of vitamin A) daily for three years and the control group took nothing. There were no significant differences between the two groups in terms of overall survival, time to disease progressio...")
08:47, 30 June 2024 DDeel talk contribs created page Publication: β-carotene supplementation in patients radically treated for stage I-II head and neck cancer: Results of a randomized trial (Created page with "{{Publication |Title=β-carotene supplementation in patients radically treated for stage I-II head and neck cancer: Results of a randomized trial |Topic=Vitamin A (beta-carotene) |Author=Toma, S; Bonelli, L; Sartoris, A; Mira, E; Antonelli, A; Beatrice, F; Giordano, C; Benazzo, M; Caroggio, A; Cavalot, AL; Gandolfo, S; Garozzo, A; Margarino, G; Schenone, G; Spadini, N; Zibordi, F; Balzarini, F; Serafini, I; Miani, P; Cortesina, G |Year=2003 |Journal=Oncology Reports |DOI...")
05:37, 28 June 2024 CHoppe talk contribs created page Attia et al. (2008): Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer (Created page with "{{Reference |Reference=Publication: Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer }} =Brief summary= This study investigated the efficacy of vitamin D in combination with docetaxel (a chemotherapeutic agent) in prostate cancer patients. One group received docetaxel and vitamin D and the other group docetaxel and placebo. There were no significant differences be...")
05:34, 28 June 2024 CHoppe talk contribs created page Publication: Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer (Created page with "{{Publication |Title=Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer |Topic=Vitamin D |Author=Attia, S; Eickhoff, J; Wilding, G; McNeel, D; Blank, J; Ahuja, H; Jumonville, A; Eastman, M; Shevrin, D; Glode, M; Alberti, D; Staab, M J; Horvath, D; Straus, J; Marnocha, R; Liu, G |Year=2008 |Journal=Clinical Cancer Research |DOI=10.1158/1078-0432.CCR-07-4274 |Authors...")
19:34, 27 June 2024 EProba talk contribs created page Lian et al. (2014): Comparing the Effectiveness of Green Tea versus Topical Metronidazole Powder in Malodorous Control of Fungating Malignant Wounds in a Controlled Randomised Study (Created page with "{{Reference |Reference=Publication: Comparing the Effectiveness of Green Tea versus Topical Metronidazole Powder in Malodorous Control of Fungating Malignant Wounds in a Controlled Randomised Study }} =Brief summary= In this study, 30 patients with malodorous malignant wounds were randomly assigned to one of two groups. In one group, the wounds were treated daily for 7 days with green tea bags and in the other group with metronidazole powder (= antibiotic in powder form)...")
19:06, 27 June 2024 EProba talk contribs created page Lian, S. B.; Xu, Y.; Goh, S. L.; Aw, F. C. (Created page with "{{Author}}")
19:06, 27 June 2024 EProba talk contribs created page Publication: Comparing the Effectiveness of Green Tea versus Topical Metronidazole Powder in Malodorous Control of Fungating Malignant Wounds in a Controlled Randomised Stud (Created page with "{{Publication |Title=Comparing the Effectiveness of Green Tea versus Topical Metronidazole Powder in Malodorous Control of Fungating Malignant Wounds in a Controlled Randomised Stud |Topic=Green tea (EGCG) |Author=Lian, S. B.; Xu, Y.; Goh, S. L.; Aw, F. C. |Year=2014 |Journal=Proceedings of Singapore Healthcare |DOI=https://doi.org/10.1177/201010581402300102 |Authors Abstract=Aim: To test the efficacy of green tea with that of conventional topical metronidazole powder by...")
11:38, 27 June 2024 CHoppe talk contribs created page Watanabe et al. (2010): Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer (Created page with "{{Reference |Reference=Publication: Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer }} =Brief summary= The study examined 31 patients with head and neck carcinoma. In addition to radiotherapy, half of the test subjects rinsed their oral cavity with a zinc solution and the other half with an azulene solution. The occurrence of inflammation of the oral mucosa (oral mucositis), pain and dry mouth (xerostomia) as we...")
11:35, 27 June 2024 CHoppe talk contribs created page Publication: Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer (Created page with "{{Publication |Title=Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer |Topic=Zinc |Author=Watanabe, T; Ishihara, M; Matsuura, K; Mizuta, K; Itoh, Y |Year=2010 |Journal=International journal of cancer |DOI=https://dx.doi.org/10.1002/ijc.25200 |Authors Abstract=Oral mucositis is frequent but serious adverse event associated with radiotherapy or radiochemotherapy in head and neck cancer severely impairs health-relat...")
10:55, 27 June 2024 CHoppe talk contribs created page Sangthawan et al. (2015): Effects of zinc sulfate supplementation on cell-mediated immune response in head and neck cancer patients treated with radiation therapy (Created page with "{{Reference |Reference=Publication: Effects of zinc sulfate supplementation on cell-mediated immune response in head and neck cancer patients treated with radiation therapy }} =Brief summary= The present study dealt with the question of the extent to which zinc supplementation influences the survival of patients with head and neck cancer. Seventy patients undergoing radiotherapy at the same time were randomly divided into two groups, one of which received zinc and the ot...")
10:53, 27 June 2024 CHoppe talk contribs created page Publication: Effects of zinc sulfate supplementation on cell-mediated immune response in head and neck cancer patients treated with radiation therapy (Created page with "{{Publication |Title=Effects of zinc sulfate supplementation on cell-mediated immune response in head and neck cancer patients treated with radiation therapy |Topic=Zinc |Author=Sangthawan, D; Phungrassami, T; Sinkitjarurnchai, W |Year=2015 |Journal=Nutrition and cancer |DOI=https://dx.doi.org/10.1080/01635581.2015.1004735 |Authors Abstract=Zinc deficiency is an important factor that impairs cellular immunity and contributes to low T lymphocyte counts in head and neck ca...")
10:01, 27 June 2024 EProba talk contribs created page Kessels et al. (2017): Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma A Randomized Clinical Trial (Created page with "{{Reference |Reference=Publication: Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma A Randomized Clinical Trial }} =Brief summary= In this study, 42 patients with superficial basal cell carcinoma were randomly assigned to one of two groups. One group received an ointment containing 55-72mg EGCG per gram, the other group a placebo ointment. Neither the participants nor the study leaders knew whether they were using the ointment with or without th...")
09:36, 27 June 2024 MKraft talk contribs created page Lichtmann et al. (2018): Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain (Created page with "{{Reference |Reference=Publication: Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain }} =Brief summary= The study included 397 patients with various types of advanced cancer. Randomly divided into 2 groups, one group received nabiximol (THC and CBD) and one group a placebo for 5 weeks. The daily dose varied from person to person, depending on...")
09:34, 27 June 2024 MKraft talk contribs created page Publication: Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain (Created page with "{{Publication |Title=Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain |Topic=Cannabinoids |Author=Lichtman, A H; Lux, E A; McQuade, R; Rossetti, S; Sanchez, R; Sun, W; Wright, S; Kornyeyeva, E; Fallon, M T |Year=2018 |Journal=Journal of Pain and Symptom Management |DOI=https://doi.org/10.1016/j.jpainsymman.2017.09.001 |Authors Abstract=Context...")
09:32, 27 June 2024 CHoppe talk contribs created page Sangthawan et al. (2013): A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients (Created page with "{{Reference |Reference=Publication: A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients }} =Brief summary= The 2013 study by Sangthawan and colleagues examined 144 patients with head and neck cancer. By random allocation, 50% of the patients were given zinc and the other half a placebo to take alongside radiotherapy. In the following weeks...")
09:31, 27 June 2024 CHoppe talk contribs deleted page Sangthawan et al. (2013: A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients (Wrong spelling)
09:28, 27 June 2024 CHoppe talk contribs created page Sangthawan et al. (2013: A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients (Created page with "{{Reference |Reference=Publication: A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients }} =Brief summary= The 2013 study by Sangthawan and colleagues examined 144 patients with head and neck cancer. By random allocation, 50% of the patients were given zinc and the other half a placebo to take alongside radiotherapy. In the following weeks...")
09:25, 27 June 2024 CHoppe talk contribs created page Publication: A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients (Created page with "{{Publication |Title=A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients |Topic=Zinc |Author=Sangthawan, D; Phungrassami, T; Sinkitjarurnchai, W |Year=2013 |Journal=Journal of the Medical Association of Thailand = Chotmaihet thangphaet |Authors Abstract=OBJECTIVE: To determine the efficacy of zinc sulfate supplementation in reducing of radi...")
09:15, 27 June 2024 EProba talk contribs created page Kessels, J.; Voeten, L.; Nelemans, P.; Cleutjens, J.; Hillen, L. M.; Mosterd, K.; Kelleners-Smeets, N. W. J. (Created page with "{{Author}}")
09:14, 27 June 2024 EProba talk contribs created page Publication: Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma: A Randomized Clinical Trial (Created page with "{{Publication |Title=Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma: A Randomized Clinical Trial |Topic=Green tea (EGCG) |Author=Kessels, J.; Voeten, L.; Nelemans, P.; Cleutjens, J.; Hillen, L. M.; Mosterd, K.; Kelleners-Smeets, N. W. J. |Year=2017 |Journal=JAMA dermatology |DOI=https://doi.org/10.1001/jamadermatol.2017.2529 |Authors Abstract=This randomized clinical trial compares topical sinecatechins ointment, 10%, vs. placebo in the treatme...")
07:26, 27 June 2024 CHoppe talk contribs created page Ripamonti et al. (1998): A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation (Created page with "{{Reference |Reference=Publication: A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation }} =Brief summary= In this study, the authors investigated the effects of zinc on changes in perception (i.e. recognizing a taste difference compared to water) and specific recognition of the tastes sour, salty, sweet and bitter. difference compared to water) and the specific reco...")
07:23, 27 June 2024 CHoppe talk contribs created page Publication: A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation (Created page with "{{Publication |Title=A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation |Topic=Zinc |Author=Ripamonti, C; Zecca, E; Brunelli, C; Fulfaro, F; Villa, S; Balzarini, A; Bombardieri, E; De Conno, F |Year=1998 |Journal=Cancer |DOI=10.1002/(sici)1097-0142(19980515)82:10<1938::aid-cncr18>3.0.co;2-u |Authors Abstract=BACKGROUND: In uncontrolled clinical trials, the administr...")
09:30, 26 June 2024 MKraft talk contribs created page Portenoy et al. (2012): Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial (Created page with "{{Reference |Reference=Publication: Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial }} =Brief summary= In this study, the effect of nabiximol, a cannabis-containing oral spray, on the personal perception of pain in patients with various advanced cancers and moderate to severe tumor pain was investigated as a function of dose. The study compared four different groups, namely three diffe...")
09:22, 26 June 2024 MKraft talk contribs created page Publication: Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial (Created page with "{{Publication |Title=Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial |Topic=Cannabinoids |Author=Portenoy, K; Ganae-Motan, E D; Allende, S; Yanagihara, R; Shaiova, L; Weinstein, S; McQuade, R; Wright, S; Fallon, M T |Year=2012 |Journal=The Journal of Pain |DOI=https://doi.org/10.1016/j.jpain.2012.01.003 |Authors Abstract=Patients with advanced cancer who have pain that responds poorly...")
12:20, 25 June 2024 JDoerfler talk contribs created page Afonseca et al. (2013): Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: A pilot randomized clinical trial (Created page with "{{Reference |Reference=Publication: Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: A pilot randomized clinical trial }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries of da...")
12:19, 25 June 2024 JDoerfler talk contribs created page Publication: Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: A pilot randomized clinical trial (Created page with "{{Publication |Title=Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: A pilot randomized clinical trial |Topic=Vitamin E |Author=Afonseca, SOd; Cruz, FM; Cubero, DDdlG; Lera, AT; Schindler, F; Okawara, M; Souza, LFd; Rodrigues, NP; Giglio, Ad |Year=2013 |Journal=Sao Paulo Medical Journal |DOI=https://doi.org/10.1590/S1516-31802013000100006 |Authors Abstract=CONTEXT AND OBJECTIVE Oxaliplatin is one of the chemotherapy regimens most used for treating...")
09:12, 25 June 2024 DDeel talk contribs created page Meyskens et al. (1995): Effects of vitamin A on survival in patients with chronic myelogenous leukemia: a SWOG randomized trial (Created page with "{{Reference |Reference=Publication: Effects of vitamin A on survival in patients with chronic myelogenous leukemia: a SWOG randomized trial }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries of dat...")
09:11, 25 June 2024 DDeel talk contribs created page Publication: Effects of vitamin A on survival in patients with chronic myelogenous leukemia: a SWOG randomized trial (Created page with "{{Publication |Title=Effects of vitamin A on survival in patients with chronic myelogenous leukemia: a SWOG randomized trial |Topic=Vitamin A (beta-carotene) |Author=Meyskens, FL; Kopecky, KJ; Appelbaum, FR; Balcerzak, SP; Samlowski, W; Hynes, H |Year=1995 |Journal=Leukemia Research |DOI=https://doi.org/10.1016/0145-2126(95)00032-J |Authors Abstract=A national cooperative group trial was conducted in 153 patients with chronic myelogenous leukemia (CML) in chronic phase t...")
08:03, 25 June 2024 JDoerfler talk contribs created page Büntzel et al. (2010): Selenium Substitution During Radiotherapy of Solid Tumours - Laboratory Data from Two Observation Studies in Gynaecological and Head and Neck Cancer Patients (Created page with "{{Reference |Reference=Publication: Selenium substitution during radiotherapy of solid tumours Laboratory data from two observation studies in gynaecological and head and neck cancer patients }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analys...")
08:02, 25 June 2024 JDoerfler talk contribs deleted page Büntzel et al. (2010): Selenium substitution during radiotherapy of solid tumors (content was: "{{Reference |Reference=Publication: Selenium substitution during radiotherapy of solid tumors }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |An...", and the only contributor was "JDoerfler" (talk))
08:00, 25 June 2024 JDoerfler talk contribs created page Büntzel et al. (2010): Selenium substitution during radiotherapy of solid tumors (Created page with "{{Reference |Reference=Publication: Selenium substitution during radiotherapy of solid tumors }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries of data collection=? |LoE=? |Outcome timeline=? }} =...")
12:53, 24 June 2024 CHoppe talk contribs created page Ribeiro et al. (2017): Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer (Created page with "{{Reference |Reference=Publication: Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer }} =Brief summary= The study described was concerned with the administration of zinc to patients with colorectal cancer and its effect on fatigue/exhaustion and life satisfaction of the patients studied. The randomly divided sample was given either zinc or a placebo. It was found that the groups did not differ in the course of the parallel...")
12:50, 24 June 2024 CHoppe talk contribs created page Publication: Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer (Created page with "{{Publication |Title=Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer |Topic=Zinc |Author=Ribeiro, SMF; Braga, CBM; Peria, FM; Martinez, EZ; Rocha, JJR; Cunha, SFC |Year=2017 |Journal=Einstein (Sao Paulo, Brazil) |DOI=https://dx.doi.org/10.1590/S1679-45082017AO3830 |Authors Abstract=Objective: To investigate the effects of oral zinc supplementation on fatigue intensity and quality of life of patients during chemotherapy fo...")
11:36, 24 June 2024 CHoppe talk contribs created page Najafizade et al. (2013): Preventive effects of zinc sulfate on taste alterations in patients under irradiation for head and neck cancers: A randomized placebo-controlled trial (Created page with "{{Reference |Reference=Publication: Preventive effects of zinc sulfate on taste alterations in patients under irradiation for head and neck cancers: A randomized placebo-controlled trial }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=?...")
11:35, 24 June 2024 CHoppe talk contribs created page Publication: Preventive effects of zinc sulfate on taste alterations in patients under irradiation for head and neck cancers: A randomized placebo-controlled trial (Created page with "{{Publication |Title=Preventive effects of zinc sulfate on taste alterations in patients under irradiation for head and neck cancers: A randomized placebo-controlled trial |Topic=Zinc |Author=Najafizade, N; Hemati, S; Gookizade, A; Berjis, N; Hashemi, M; Vejdani, S; Ghannadi, A; Shahsanaee, A; Arbab, N |Year=2013 |Journal=Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences |DOI=https://www.ncbi.nlm.nih.gov/pmc/articles...")
10:35, 24 June 2024 EProba talk contribs created page Crew et al. (2012): Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer (Created page with "{{Reference |Reference=Publication: Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer }} =Brief summary= In this dose-escalating study, some participants were initially given 400mg EGCG (in the form of polyphenon E capsules) twice a day. As soon as someone reported a severe side effect (grade II according to CTCAE), it was looked at again and calculated how likely it was...")
10:22, 24 June 2024 EProba talk contribs created page Crew, K. D.; Brown, P.; Greenlee, H.; Bevers, T. B.; Arun, B.; Hudis, C.; McArthur, H. L.; Chang, J.; Rimawi, M.; Vornik, L.; Cornelison, T. L.; Wang, A.; Hibshoosh, H.; Ahmed, A.; Terry, M. B.; Santella, R. M.; Lippman, S. M.; Hershman, D. L. (Created page with "{{Author}}")
10:21, 24 June 2024 EProba talk contribs created page Publication: Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer (Created page with "{{Publication |Title=Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer |Topic=Green tea (EGCG) |Author=Crew, K. D.; Brown, P.; Greenlee, H.; Bevers, T. B.; Arun, B.; Hudis, C.; McArthur, H. L.; Chang, J.; Rimawi, M.; Vornik, L.; Cornelison, T. L.; Wang, A.; Hibshoosh, H.; Ahmed, A.; Terry, M. B.; Santella, R. M.; Lippman, S. M.; Hershman, D. L. |Year=2012 |Journal=Cancer...")
10:05, 24 June 2024 MKraft talk contribs created page Johnson et al. (2010): Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain (Created page with "{{Reference |Reference=Publication: Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain }} =Brief summary= In this study, 177 patients with advanced cancer were randomly divided into 3 groups. One group received THC and CBD for 2 weeks, the other group only THC and the last group a placebo. The daily dose varied from pe...")
09:59, 24 June 2024 MKraft talk contribs created page Publication: Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain (Created page with "{{Publication |Title=Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain |Topic=Cannabinoids |Author=Johnson, J R; Burnell-Nugent, M; Lossignol, D; Ganae-Motan, E D; Potts, R; Fallon, M T |Year=2010 |Journal=Journal of pain and symptom management |DOI=https://doi.org/10.1016/j.jpainsymman.2009.06.008 |Authors Abstract=T...")
08:49, 21 June 2024 CHoppe talk contribs created page Moslemi et al. (2014): Oral zinc sulphate and prevention of radiation-induced oropharyngealmucositis in patients with head and neck cancers: A double blind, randomized controlled clinical trial (Created page with "{{Reference |Reference=Publication: Oral zinc sulphate and prevention of radiation-induced oropharyngealmucositis in patients with head and neck cancers: A double blind, randomized controlled clinical trial }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomiz...")
08:48, 21 June 2024 CHoppe talk contribs created page Publication: Oral zinc sulphate and prevention of radiation-induced oropharyngealmucositis in patients with head and neck cancers: A double blind, randomized controlled clinical trial (Created page with "{{Publication |Title=Oral zinc sulphate and prevention of radiation-induced oropharyngealmucositis in patients with head and neck cancers: A double blind, randomized controlled clinical trial |Topic=Zinc |Author=Moslemi, D; Babaee, N; Damavandi, M; Pourghasem, M; Moghadamnia AA |Year=2014 |Journal=International Journal of Radiation Research |DOI=https://ijrr.com/browse.php?a_id=1281&sid=1&slc_lang=en |Authors Abstract=Background: This research was conducted to evaluate t...")
07:50, 21 June 2024 CHoppe talk contribs created page Lyckholm et al. (2012): A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders (Created page with "{{Reference |Reference=Publication: A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries of data...")
07:36, 21 June 2024 CHoppe talk contribs created page Publication: A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders (Created page with "{{Publication |Title=A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders |Topic=Zinc |Author=Lyckholm, L; Heddinger, SP; Parker, G; Coyne, PJ; Ramakrishnan, V; Smith, TJ; Henkin, RI |Year=2012 |Journal=Journal of pain & palliative care pharmacotherapy |DOI=10.3109/15360288.2012.676618 |Authors Abstract=Abnormalities in taste and smell are commonly reported in patients receiving chemotherapy and may hinder appetite, dieta...")